ImmunityBio (IBRX) Other Non-Current Liabilities (2014 - 2026)
ImmunityBio (IBRX) reported Other Non-Current Liabilities of $352.38 million for Q2 2026, up 426.3% from $66.96 million a year earlier and up 14.3% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, ImmunityBio posted Other Non-Current Liabilities of $84.42 million, up 223.2% from FY2024.
- Other Non-Current Liabilities has a five-year compound annual growth rate of 141.2% (FY2020 to FY2025).
- By year, Other Non-Current Liabilities came in at $26.12 million in FY2024 (-78.0%), $118.77 million in FY2023 (+448.9%), $21.64 million in FY2022 and $411,000 in FY2021 (-60.3%).
- The Q2 2026 figure ranks as the highest quarterly Other Non-Current Liabilities in data going back to Q4 2014.
- Year over year, Other Non-Current Liabilities gained in four of the last seven quarters, with growth averaging 134.3%.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q1 2024 (growth of 518.6%); the low point was Q1 2025 (a decline of 81.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $308.19 million (Q1 2026), $84.42 million (Q4 2025) and $115.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | ImmunityBio | 9.07 Bn | 7.83 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 376.90 Mn |
| Mar 31, 2026 | 331.98 Mn |
| Dec 31, 2025 | 104.56 Mn |
| Sep 30, 2025 | 134.18 Mn |
| Jun 30, 2025 | 86.28 Mn |
| Mar 31, 2025 | 29.94 Mn |
| Dec 31, 2024 | 35.01 Mn |
| Sep 30, 2024 | 38.24 Mn |
| Jun 30, 2024 | 86.91 Mn |
| Mar 31, 2024 | 149.20 Mn |
| Dec 31, 2023 | 155.21 Mn |
| Sep 30, 2023 | 39.84 Mn |
| Jun 30, 2023 | 28.27 Mn |
| Mar 31, 2023 | 18.24 Mn |
| Dec 31, 2022 | 22.09 Mn |
| Sep 30, 2022 | 569,000.00 |
| Jun 30, 2022 | 290,000.00 |
| Mar 31, 2022 | 288,000.00 |
| Dec 31, 2021 | 411,000.00 |
| Sep 30, 2021 | 905,000.00 |
API Access
ImmunityBio Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();